Abbruzzese JL - Search Results

1

Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.

Davis DW, Takamori R, Raut CP, Xiong HQ, Herbst RS, Stadler WM, Heymach JV, Demetri GD, Rashid A, Shen Y, Wen S, Abbruzzese JL, McConkey DJ. Davis DW, et al. Among authors: abbruzzese jl. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):678-89. Clin Cancer Res. 2005. PMID: 15701856

2

Synergistic cytotoxicity with 2'-deoxy-5-azacytidine and topotecan in vitro and in vivo.

Anzai H, Frost P, Abbruzzese JL. Anzai H, et al. Among authors: abbruzzese jl. Cancer Res. 1992 Apr 15;52(8):2180-5. Cancer Res. 1992. PMID: 1373105

3

Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer.

Abbruzzese JL, Levin B, Ajani JA, Faintuch JS, Saks S, Patt YZ, Edwards C, Ende K, Gutterman JU. Abbruzzese JL, et al. Cancer Res. 1989 Jul 15;49(14):4057-61. Cancer Res. 1989. PMID: 2500234

4

Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.

Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Abbruzzese JL, Zhang W, Chiao PJ. Grau AM, et al. Among authors: abbruzzese jl. Cancer Res. 1997 Sep 15;57(18):3929-34. Cancer Res. 1997. PMID: 9307274

5

Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.

Ferrandina G, Melichar B, Loercher A, Verschraegen CF, Kudelka AP, Edwards CL, Scambia G, Kavanagh JJ, Abbruzzese JL, Freedman RS. Ferrandina G, et al. Among authors: abbruzzese jl. Cancer Res. 1997 Oct 1;57(19):4309-15. Cancer Res. 1997. PMID: 9331092

6

DNA adducts in human pancreatic tissues and their potential role in carcinogenesis.

Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, Chiao P, Li D. Wang M, et al. Among authors: abbruzzese mc, abbruzzese jl. Cancer Res. 1998 Jan 1;58(1):38-41. Cancer Res. 1998. PMID: 9426054

7

Docetaxel enhances tumor radioresponse in vivo.

Mason KA, Hunter NR, Milas M, Abbruzzese JL, Milas L. Mason KA, et al. Among authors: abbruzzese jl. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2431-8. Clin Cancer Res. 1997. PMID: 9815644

8

bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.

Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL. Sinicrope FA, et al. Among authors: abbruzzese jl. Clin Cancer Res. 1996 Dec;2(12):2015-22. Clin Cancer Res. 1996. PMID: 9816161

9

Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor.

Abbruzzese JL, Madden T, Sugarman SM, Ellis AL, Loughlin S, Hess KR, Newman RA, Zwelling LA, Raber MN. Abbruzzese JL, et al. Clin Cancer Res. 1996 Sep;2(9):1489-97. Clin Cancer Res. 1996. PMID: 9816325 Clinical Trial.

10

Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines.

Melichar B, Ferrandina G, Verschraegen CF, Loercher A, Abbruzzese JL, Freedman RS. Melichar B, et al. Among authors: abbruzzese jl. Clin Cancer Res. 1998 Dec;4(12):3069-76. Clin Cancer Res. 1998. PMID: 9865922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters